# EDGAR Filing Document

**Accession Number:** 0002025942
**File Stem:** 0001493152-25-012296
**Filing Date:** 2025-8
**Character Count:** 3740
**Document Hash:** 49abfd086c9cb53568c87d8da4992e62
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-012296.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001493152-25-012296

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250825

**DATE AS OF CHANGE**: 20250825

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Curanex Pharmaceuticals Inc
- **CENTRAL INDEX KEY:** 0002025942
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 830741390
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42815
- **FILM NUMBER:** 251248570

**BUSINESS ADDRESS:**
- **STREET 1:** 2 JERICHO PLAZA,
- **STREET 2:** SUITE101B
- **CITY:** JERICHO
- **STATE:** NY
- **ZIP:** 11753
- **BUSINESS PHONE:** 718-673-6078

**MAIL ADDRESS:**
- **STREET 1:** 2 JERICHO PLAZA,
- **STREET 2:** SUITE101B
- **CITY:** JERICHO
- **STATE:** NY
- **ZIP:** 11753

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington D.C. 20549**

**Form 8-A**

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES**

**PURSUANT TO SECTION 12(b) OR (g) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**CURANEX PHARMACEUTICALS INC**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **83-0741390** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

**2 Jericho Plaza, Suite 101B**

**Jericho, NY 11753**

(Address of principal executive offices)

Securities to be registered pursuant to Section 12(b) of the Act

---

| | |
|:---|:---|
| Title of each class to be so registered | Name of each exchange on which each class is to be registered |
| **Common Stock, par value $0.0001 per share** | **The Nasdaq Stock Market LLC** |

---

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ☐

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

Securities Act registration statement file number to which this form relates: **333-282686**

(if applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

**<u>None</u>**

(Title of class)

**Item 1. Description of Registrant's Securities to be Registered.**

The description of securities contained in Registrant's Registration Statement on Form S-1, as amended, filed with the Commission (File No. 333-282686) is incorporated by reference into this registration statement.

**Item 2. Exhibits**

Pursuant to the "Instructions as to Exhibits" section of Form 8-A, no exhibits are required to be filed because no other securities of the registrant are to be registered on The Nasdaq Capital Market and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

**SIGNATURE**

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | |
|:---|:---|
| Date: August 25, 2025 | Date: August 25, 2025 |
| **Curanex Pharmaceuticals Inc** | **Curanex Pharmaceuticals Inc** |
| By: | */s/ Jun Liu* |
|  | Jun Liu |
| Title: | Chief Executive Officer |

---